HELLP syndrome (HELLP), second trimester
ICD-10 O14.22 is a billable code used to indicate a diagnosis of hellp syndrome (hellp), second trimester.
HELLP syndrome is a severe form of pre-eclampsia characterized by hemolysis, elevated liver enzymes, and low platelet count. It typically occurs in the second trimester or early third trimester of pregnancy and can lead to serious maternal and fetal complications if not promptly diagnosed and managed. The condition is often associated with severe features of pre-eclampsia, including hypertension and proteinuria. Symptoms may include abdominal pain, nausea, vomiting, and headache. Diagnosis is confirmed through laboratory tests showing elevated liver enzymes, low platelet count, and signs of hemolysis. Management often involves the administration of magnesium sulfate to prevent seizures, along with close monitoring of maternal and fetal well-being. Delivery is usually indicated, especially if the mother or fetus is in distress, as this is the only definitive treatment for HELLP syndrome. Early recognition and intervention are crucial to improving outcomes for both mother and baby.
Detailed documentation of maternal symptoms, laboratory results, and treatment protocols is essential for accurate coding.
Management of a patient presenting with severe hypertension and elevated liver enzymes in the second trimester.
Coders must ensure that all relevant clinical features are documented to support the diagnosis of HELLP syndrome.
Comprehensive documentation of high-risk factors, fetal monitoring, and maternal health status is critical.
Monitoring and managing a patient with HELLP syndrome who requires close observation and potential early delivery.
High-risk coding requires attention to detail in documenting maternal and fetal outcomes.
Used for genetic testing in a patient with HELLP syndrome to assess fetal well-being.
Document indications for amniocentesis and maternal consent.
Maternal-fetal medicine specialists should ensure that risks are communicated to the patient.
Key symptoms include severe headache, abdominal pain, nausea, vomiting, and visual disturbances. Laboratory tests will show elevated liver enzymes, low platelet count, and signs of hemolysis.
